PVH
55
10
WU
18
-20
AAPL
50
-3
KHC
40
2
KMX
36
-11
XYL
45
-2
AIG
44
-3
WM
56
-12
TSCO
46
-3
GRMN
56
-3
FRT
41
-4
GM
49
-14
TXT
65
-4
GOOG
75
-4
BEN
37
-3
MLM
70
-2
CNX
67
-4
ILMN
33
-9
CINF
48
-3
INTC
48
4
PVH
55
10
WU
18
-20
AAPL
50
-3
KHC
40
2
KMX
36
-11
XYL
45
-2
AIG
44
-3
WM
56
-12
TSCO
46
-3
GRMN
56
-3
FRT
41
-4
GM
49
-14
TXT
65
-4
GOOG
75
-4
BEN
37
-3
MLM
70
-2
CNX
67
-4
ILMN
33
-9
CINF
48
-3
INTC
48
4
Financhill
Back

Ryman Hospitality Properties Vs. Akero Therapeutics Industry Stock Comparison

Buy
61

RHP
Ryman Hospitality Properties

Last Price:
109.35
Seasonality Move:
-0.34%
Sell
36

AKRO
Akero Therapeutics

Last Price:
21.72
Seasonality Move:
19.37%
Buy
61
Ryman Hospitality Properties (RHP) is a Buy

Is Ryman Hospitality Properties a Buy, Sell or Hold?

  • The current Ryman Hospitality Properties [RHP] share price is $109.44. The Score for RHP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • RHP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $21.79. The Score for AKRO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RHP Stock Price Chart

What is Ryman Hospitality Properties's stock price today?

  • The Ryman Hospitality Properties share price today is $109.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHP is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $21.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.

RHP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.18 Sell
Relative Strength Index (14 RSI): 34.2 Sell
Chaikin Money Flow: -344755 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.02 - 117.14) Sell
Bollinger Bands (100): (106.08 - 117.6) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1 Sell
Relative Strength Index (14 RSI): 36.18 Sell
Chaikin Money Flow: -196762 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.63 - 26.91) Sell
Bollinger Bands (100): (19.26 - 26.18) Sell

RHP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 113.46 Sell
20-day SMA: 114.92 Sell
50-day SMA: 115.92 Sell
200-day SMA: 100.05 Buy
8-day EMA: 112.67 Sell
20-day EMA: 114.28 Sell
50-day EMA: 114.23 Sell
200-day EMA: 103.98 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.59 Sell
20-day SMA: 23.93 Sell
50-day SMA: 24.46 Sell
200-day SMA: 29.92 Sell
8-day EMA: 22.57 Sell
20-day EMA: 23.74 Sell
50-day EMA: 24.19 Sell
200-day EMA: 28.09 Sell

Ryman Hospitality Properties Earnings Growth & RHP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.07 per share, and an increase next year of $1.17 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.

Ryman Hospitality Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):